LEADER 00950cam0-2200349---450 001 990004017890403321 005 20230920133139.0 010 $a88-06-05749-9 035 $a000401789 035 $aFED01000401789 035 $a(Aleph)000401789FED01 035 $a000401789 100 $a19990604d1984----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $a--------001gy 200 1 $aCanzoni e sonetti$fDino Frescobaldi$ga cura di Furio Brugnolo 210 $aTorino$cEinaudi$d1984 215 $a95 p.$d18 cm 225 1 $aCollezione di poesia$v187 676 $a851.1 700 1$aFrescobaldi,$bDino$f<1271-ca.1316>$0152359 702 1$aBrugnolo,$bFurio 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990004017890403321 952 $a808.81 COLBIANCA 187$bDip.f.m.346$fFLFBC 952 $aF.Russo 11$fBAT 959 $aFLFBC 959 $aBAT 996 $aCanzoni e sonetti$9201422 997 $aUNINA LEADER 03966nam 2201093z- 450 001 9910576881803321 005 20220621 035 $a(CKB)5720000000008357 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/84467 035 $a(oapen)doab84467 035 $a(EXLCZ)995720000000008357 100 $a20202206d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aDiagnosis and Management of Heart Failure 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 online resource (202 p.) 311 08$a3-0365-4154-3 311 08$a3-0365-4153-5 330 $aHeart failure prevalence continues to rise globally. Regardless of the underlying etiology, heart failure remains a progressive disease, largely irreversible and end-stage heart failure requires transplantation. Book focuses on the challenges and recent advances of diagnosis, treatment and prevention of heart failure with or without associated comorbidities. We hope that readers will appreciate the wide breadth of topics and clinical utility of the articles and reviews included to this book collection. 606 $aCardiovascular medicine$2bicssc 606 $aMedicine and Nursing$2bicssc 610 $a24-h ECG monitoring 610 $a2D echocardiography 610 $aacute myocardial infarction 610 $aadverse left ventricular remodeling 610 $aangiotensin receptor-neprilysin inhibitor 610 $aarteriovenous fistulas 610 $abiomarkers 610 $ablood biomarkers 610 $acardiac allograft vasculopathy 610 $acardiopulmonary exercise test 610 $acardiovascular disease 610 $achronic heart failure 610 $achronic kidney disease 610 $aclinical assessment 610 $acongestion 610 $adiagnosis 610 $adilated cardiomyopathy 610 $aE/e' ratio 610 $aechocardiography 610 $aedema 610 $aejection fraction 610 $aendothelial dysfunction 610 $aepicardial fat 610 $afatty liver 610 $afibrosis 610 $afluid management 610 $agalectin-3 610 $aheart failure 610 $aheart failure readmission 610 $aheart rate variability 610 $aheart transplant 610 $aheart transplant rejection 610 $aHFrEF 610 $ahospitalization predictor 610 $aleft atrial strain 610 $aleft ventricle end-diastolic diameter 610 $aleft ventricle outflow tract velocity-time integral 610 $aleft ventricular-arterial coupling 610 $alongitudinal strain 610 $amatrix metalloproteinases 610 $amortality 610 $amyocardial infarction 610 $an/a 610 $aNT-proBNP 610 $aoverhydration 610 $apacing parameters 610 $apreserved ejection fraction 610 $apreserved left ventricular ejection fraction 610 $apulmonary hypertension 610 $areduced left ventricular ejection fraction 610 $arisk stratification 610 $asensing parameters 610 $ashort-term prognosis 610 $asoluble ST2 610 $aST-segment elevation myocardial infarction 610 $atissue inhibitors of metalloproteinases 610 $atransthoracic echocardiography 610 $atype 2 diabetes mellitus 610 $aventilatory inefficiency 615 7$aCardiovascular medicine 615 7$aMedicine and Nursing 700 $aGladysheva$b Inna P$4edt$01300064 702 $aSullivan$b Ryan D$4edt 702 $aGladysheva$b Inna P$4oth 702 $aSullivan$b Ryan D$4oth 906 $aBOOK 912 $a9910576881803321 996 $aDiagnosis and Management of Heart Failure$93025392 997 $aUNINA